These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19897776)

  • 21. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
    Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
    Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Kandzari DE; Goldschmidt-Clermont PJ
    JAMA; 1999 Feb; 281(5):415; author reply 417-9. PubMed ID: 9952193
    [No Abstract]   [Full Text] [Related]  

  • 23. Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
    Piednoir P; Quesnel C; Nardelli L; Leçon V; Bouadma L; Lasocki S; Philip I; Mailleux A; Soler P; Crestani B; Dehoux M
    Crit Care Med; 2012 Jul; 40(7):2041-9. PubMed ID: 22713216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins reduce ambient particulate matter-induced lung inflammation by promoting the clearance of particulate matter, < 10 μm from lung tissues.
    Miyata R; Bai N; Vincent R; Sin DD; Van Eeden SF
    Chest; 2013 Feb; 143(2):452-460. PubMed ID: 22910717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
    Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
    Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG-CoA reductase inhibitors reduce stroke risk, total mortality.
    Am J Health Syst Pharm; 1997 Oct; 54(19):2152, 2154. PubMed ID: 9331434
    [No Abstract]   [Full Text] [Related]  

  • 27. Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury.
    Wu Y; Lv J; Feng D; Jiang F; Fan X; Zhang Z; Yin R; Xu L
    Int J Mol Med; 2012 Dec; 30(6):1294-306. PubMed ID: 23076613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion.
    Naidu BV; Woolley SM; Farivar AS; Thomas R; Fraga C; Mulligan MS
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):482-9. PubMed ID: 12928648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.
    Yeo CD; Rhee CK; Kim IK; Kang HH; Lee SH; Lee SY; Kwon SS; Kim YK; Kim KH; Kim JW
    Exp Lung Res; 2013 Mar; 39(2):99-106. PubMed ID: 23368428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model.
    Mohammadian M; Sadeghipour HR; Kashani IR; Jahromi GP; Omidi A; Nejad AK; Golchoobian R; Boskabady MH
    Lung; 2016 Oct; 194(5):777-85. PubMed ID: 27161569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of statins in the treatment of heart failure.
    Ramasubbu K; Mann DL
    J Am Coll Cardiol; 2006 Jan; 47(2):342-4. PubMed ID: 16412858
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repair of lipopolysaccharide-induced acute lung injury in mice by endothelial progenitor cells, alone and in combination with simvastatin.
    Li H; Qiang Y; Wang L; Wang G; Yi J; Jing H; Wu H
    Chest; 2013 Sep; 144(3):876-886. PubMed ID: 23539119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy.
    Bottorff MB; Yenkowsky JP; Cave DG
    Clin Ther; 1999 Jan; 21(1):218-35. PubMed ID: 10090437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy.
    Mehdorn AS; Palmes D; Dhayat S
    Ann Surg; 2015 Dec; 262(6):e119. PubMed ID: 25371120
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.